US Stock MarketDetailed Quotes

XCUR Exicure

Watchlist
  • 17.5600
  • -0.9700-5.23%
Close Dec 18 16:00 ET
  • 17.5000
  • -0.0600-0.34%
Pre 07:26 ET
45.76MMarket Cap-8.69P/E (TTM)

About Exicure Company

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Company Profile

SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul Kang
  • Director, Chief Executive Officer and President
  • 16.94K
  • Jiyoung Hwang
  • Director and Chief Financial Officer
  • 16.97K
  • Joshua Miller
  • Chief Accounting Officer
  • --
  • Andy Yoo
  • Director and Chief Restructuring Officer
  • --
  • Seung Ik Baik
  • Director
  • --
  • Dongho Lee
  • Independent Director
  • 7.22K
  • Hyuk Joon Ko
  • Independent Director
  • 7.22K
  • Minhee Eom
  • Independent Director
  • 5.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data